Capricor Therapeutics Inc【CAPR】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 8-K - Current report

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

-If approved, deramiocel would be first approved therapy for Duchenne muscular dystrophy cardiomyopathy- -BLA...

Form 4 - Statement of changes in beneficial ownership of securities

Capricor Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announced intent to file a biologics license application (BLA) for deramiocel to treat all patients with...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

👍️0

MomsSpaghetti 1週前

My question to you CAPR folks who are likely more versed than I. Is after the submission is sent to FDA for approval (in your case Deramiocel (CAP-1002)) - How long does it take FDA to make a decision on average?

I am following another company MNMD that is in Phase 3 right now for LSD that got FDA Break Through Designation.

👍️0

GreedyAgorist 2週前

Guess I was wrong about the new 5. It is not 20 or 17.50. Not yet. Those were the pump prices. If the pump is over for now, we might hang out around 12.50 for a while, making puts at 12.50 and 10 interesting. Likewise calls at 15 might be worth a shot. Although my next play is targeting March 17.50. If it gets there early, that will inform my next move.

👍️0

XWAVXALMIMAN 4週前

You’ll be sorry. Definitely an easy double from here within a year. I’ve held most shares for 4 1/2 years. Be patient. Linda sounded great - listened to interview last night after 12 days in Puerto Vallarta

👍️ 1

Laster 4週前

Got out yesterday afternoon before that huge dump.
It looked like it wanted to drop below $16.
Crazy AH trading down to $11 and back to $16.
Concern about one of their investigators.
Either way, I am out and hope others can make a better trade than I did. Now moving my money to other more quality stocks. JMO.

👍️0

D-bol 4週前

What a day. Still not selling.

👍️0

PonkenPlonken 4週前

RFK is irrelevant to how CAPR moves.

Everything is in the price here... plus a lot of birds in the bush. Why anyone would hold this stock AFTER it all happened, no catalyst on the horizeon. Presentation roadmap ends at "today".... is clear indication they know nothing will happen for a good year or two. So it will need a breather - which I believe you see in the chart.

Bios run towards events - not because of them.
GL

👍️0

Laster 4週前

Thank you. I have patience and can wait for mid 2025.
The problem is the biotech sector. It has gotten destroyed since Trump picked RFK Jr. as HHS secretary. Hopefully it will recover if RFK Jr. somehow doesn’t get the job.
Just hate the BS manipulation to drop stocks on no news. The stock market is a joke. Many Stocks now move on no news. I have seen stocks move from $1 to $10 on nothing. How is that possible or legal?
Just hope it doesn’t drop lower than $15. Then I might have to throw in the towel and move on.

👍️0

PonkenPlonken 1月前

This stock trades on a lot of hopes, dreams and "ifs".
Not unlikely that whatever they announce, it will be a sell on news event.
It believe it has to cool off until the PDUFA which is ca 1 year away.
When the roadmap a company gives in their presentation ends with "today"...... is usually not a good sign. That is speaking in terms of PPS. For the company, everything is well and funding wont be an issue.

👍️0

Laster 1月前

Now down to $17.50. WOW. I can only guess people were expecting news on the BLA submission.
Maybe they are getting financing through the ATM and selling into the market.
Either way, this doesn't look good today.

👍️0

Laster 1月前

This stock is ridiculous. I don't know if it is manipulation or MMs getting the stop losses?
Opened at $19.44 and then in 1 minute it went to $20.75 and then the next minute it is down to $18.92.
Clearly, someone continues to keep this below $20. When will they be done????
This is criminal IMO. I am holding because I think it makes a run to $30 once all this crap is over.
MACD histogram on the daily is going to turn positive today.
JMO.

👍️0

Laster 1月前

The stock chart looks interesting. The MACD histogram is ready to turn positive.
The stock found support at the 25 day moving average.
PnF chart clearly shows double/triple top breakout past $21.
Nice flag forming. Needs volume to move past $20.
I think the stock will need BLA news to get the volume to move past $20.
I am looking for $30-$40 by mid 2025.

FYI. Conferences this week and next week.
Perfect time to release some updates.

👍 1

Laster 1月前

Well yesterday sucked. Moved BACK to $20 again only to get dumped back down to $19.
Looks like it will need significant volume to move back above $20.
2 conferences in early to mid December might help.
Happy Thanksgiving.

👍️0

Laster 1月前

I am looking for a firm break past $20 before end of the year.
I am hopeful for continued movement early 2025.
I like stocks that hold up well during sector selloff.
JMO.

👍️0

Laster 1月前

Holding up well in bad biotech market right now.
Break $20 and this could get Interesting.

👍️0

Mionaer1 1月前

https://d1io3yog0oux5.cloudfront.net/_a2273a855b16264d98c228e2a432c4ee/capricor/news/2024-11-20_Capricor_Therapeutics_Granted_Orphan_Drug_and_301.pdf

Great news.

👍️0

Mionaer1 2月前

Trading range $17-22 IMO. When BLA ready (end of 2024) $30 IMO.

👍️ 1

ed3/6me 2月前

Thought it would've 17 so close. Only have pennies so can't buy much but figure the next level and 23/24. Down to 19/20 then bumping up past 30

👍 1

GreedyAgorist 2月前

Looks like you nearly nailed that floor price.

So, the first reaction to the quarterly numbers makes sense: down on still no P/E ratio (i.e., negative earnings). And then a bounce, presumably thanks to bargain hunters who think that if 20 is a bargain, then 17 is a steal.

We seem to be settling in price-wise. It's not just FOMO* up like last month, although we can, with some regularity, still get 10-15% swings either way to keep it interesting. For options traders like me, who, before the FDA/BLA news, have been buying under 5 and selling covered calls (mostly at 5, with the occasional 7.5 thrown in there) the only question is: What is the new 5? 20 or 17.50?

*with a little BTFD mixed in

👍️0

Laster 2月前

Excellent that $21 support held. I was nervous for a little bit.
Now let’s break $22.50 so we can have clear sailing to $30 with target $35.
I am confident (sort of) that this will occur.
Here’s hoping.

👍 1

Laster 2月前

Failed $22.50 break multiple times.
Probably time to consolidate before next run.
Might drop and find support at $19.50.
Hopefully not.
Still looking and hoping for volume to power this past $22.50 for good.

👍️0

Laster 2月前

The stock chart is showing a nice ascending triangle from Sept 30th breakout from $10.
Using my novice chart skills, I get a target of $35 for the stock (flag pole from $10 to resistance at $22.50 = $12.50).
$22.50 plus $12.50 = $35. Sounds good to me.
Lower trendline has shown nice support but if the stock moves back to $20 then stock might drop back to $17.50.
Let’s what happens this week.
Hoping for move to $25 if the market looks good.

👍️0

staynafloat 2月前

I think what helped the most is that the OS is only 44.7 Mil. with that added in. It appears that a lot of traders are holding making it trade very thin.

LOL ... I've been waiting for almost 5 years for this to go thru all the trials and testing and it sure is sweet :)

👍️0

GreedyAgorist 2月前

That dilution went about as well as any I’ve seen. The news did not even bring us below 18 for more than a wick or two. Correct me if I’m wrong, but the underwriters made out quite well, at least an extra dollar per additional share issued (~5M). Nice work if you can get it.

👍️0

Laster 2月前

Sounds good.
Hopefully yesterday was a technical sell off to show $20 support level.
Maybe get rid of those low hanging stop loss orders.
I am not worried about another financing so I expect a nice move to $25 then $30 by EOY.
Enjoy.

👍️0

XWAVXALMIMAN 2月前

No comment on Blackrock report owning over 5% of Capricor?
30 will be here soon. Maybe a short squeeze will pop us up to 40

👍️0

Laster 2月前

You never know but these $20 stocks tend to move to $25 or even $30.
I wouldn’t mind a nice 25% profit here.

👍️0

Volcano 2月前

The small float is getting locked up by big boys everyday
My prediction $30 by Thanksgiving and $50 by Christmas and $100 upon FDA approval in early next year
Thus became the millionaire stock indeed

👍️0

Mionaer1 2月前

Piper Sandler PT $35

Piper Sandler analyst Edward Tenthoff initiates coverage on Capricor Therapeutics (NASDAQ: $CAPR) with an Overweight rating and a price target of $35.00.

The analyst comments: "Capricor is developing deramiocel (CAP-1002) to treat cardiomyopathy in Duchenne Muscular Dystrophy (DMD) boys. In the Phase II HOPE-2 trial (N=20), deramiocel slowed LVEF decline by 107% vs. placebo at 12 months. (p=0.002) At World Muscle Society, HOPE-2 OLE data showed deramiocel achieved an 8.1 point improvement in median LVEF and 11.0ml/m2 benefit in median End Systolic Volume vs. external controls at 2 years with benefit maintained out to 3 years. Capricor has begun the rolling BLA submission, and deramiocel could gain FDA approval for DMD cardiomyopathy in 2H:25. Deramiocel is partnered globally with Nippon Shinyaku with Capricor retaining 30-50% of potential blockbuster revenues, plus up to $1.5 billion in milestones. Capricor recently issued 5.1 million shares at $17 raising gross proceeds of $86 million, bringing pro forma cash to ~ $198 million excluding 3Q:24 burn."

$12? Never. $17 is the new floor IMO.

👍️0

ed3/6me 2月前

My thought is slide back to 12-15 then move to 21-25. Dip again then about 20%up. Never straight unless flooring news

👍️0

Volcano 2月前

This beast will keep moving up in the coming days
FDA approval is guaranteed and secured huge fund
I expect $50 by Christmas and $100 next year
I am a millionaire here

👍️0

GreedyAgorist 3月前

Looks like they are not even asking enough for them.

"Capricor Therapeutics (CAPR) said Thursday that it priced an underwritten offering of about 4.4 million shares at $17 per share..."

I knew the dilution was coming. I guess I was hoping that news would be later, not this week. Like the earnings report that will be a negative number (but not as negative as last quarter).

Dips are buying opportunities, but when they are based on fundamental rules of supply and demand, I wonder if there is a hurry any more. Need to know what the new plateau is. Again, I guess it was too much to ask for that to be established after this week.

: - }

👍️0

XWAVXALMIMAN 3月前

It looked like we would hold at 20. Then they diluted our shares. I hate when that happens. Didn’t they have enough cash to survive until we would be profitable? Hopefully good news is coming and that extra money will be used for growth

👍️0

GreedyAgorist 3月前

Arrgghh, they could not wait to dilute, huh? I just needed a couple more days.

Feels like somebody got the info early, too. I have to wonder what price they are getting. Today's high? The after hours' low?

👍️0

ed3/6me 3月前

They sell today? Would be another k in your pocket

👍️0

XWAVXALMIMAN 3月前

Great day today. We started out down and then reversed and had trouble getting thru 20. Since I was having eye surgery today, I put in to sell 7250 shares at 20.20. It looked good for a while when we went down to low 19’s. I tried to buy back at 18.65 but never got there. This was my 3rd time selling and buying back and selling again. I’m done. Keeping my 40.000 shares until we get to 30-40.

We ran up to 23.40 before some profit taking. Some of you are looking for a 10% correction. I use Fibonacci numbers / Elliott Wave.
We went from 4 to 22 which is 18 and then went down to around 15; a 7 point retracement. 7/18 is around 38%.

Next Wave took us from 15 to 23+. Going up 8 points means that selling should take us down 3. Expect support at 20 before the next big up move.Have a great week. Let’s Go Mets and Guardians!

👍️0

D-bol 3月前

DRUG We need a move like this one today!!

Yep
Still waiting for $100 Pps

👍️0

D-bol 3月前

Volcano are you still here? Haven’t heard from you in a while.

👍️0

GreedyAgorist 3月前

Just another day at the office with Capricor. Up 15%+ again. Do we get the 10% sell off before resuming the climb? That would still be a respectable gain of 7.5%. If we close above 22, that will be rarefied air for anyone in this for less than 6 years. Held the 21 handle briefly two weeks ago.

I have already played a couple of dips this week. Now waiting for a legitimate correction.

👍️0

XWAVXALMIMAN 3月前

Thanks Ed. I tried to sell 7250 at 19.80 which I had bought at 18.80. Still holding my 40,000 shares.
I’m buying some XRP with my profits and averaging down on some of my other losers. taking out some cash for vacations

👍️0

TechandBio 3月前

Next leg up will come in time patience!

$CAPR

👍️0

ed3/6me 3月前

agree. think retracement over till 25-30 range then probably 20% retract. but for the most part your bulk idea is solid. using 20-25% of your shares is a good way to hedge and try to get free shares. You already have profit so use it.

👍️0

XWAVXALMIMAN 3月前

15.35 could be a good retracement of about 35% of the gain. We might retest that level but I wouldn’t risk it.
HC Wainwright raised their target from 40 to 70. I’m holding my core of 40,000 shares but I’m trading 7-10,000 shares for travel spending money. Planning a safari for my wife’s 70th. Sold over 20 twice and bought back at 17-18. If I can make 2-3 several times I’ll take it. If I sell and it never comes down for me to buy back, that’s fine too. I’ll still have my core. Good luck to everyone.

👍️0

GreedyAgorist 3月前

Day trading this one would have been fun. Actually, since there are only monthly options available on Capricor, I just sold a few more contracts expiring next week. I hardly ever buy options any more, although I did get into and out of a couple contracts expiring today on another ticker. Used the profit to cover the cost of a protective put here on this one. That should calm the nerves a bit next week as the expiration clock starts ticking louder. Not rooting for a down Monday, but if it comes, I will be ready.

Note to self: buy low, sell high.

👍️0

ed3/6me 3月前

You get in some day trade action?

👍️0

GreedyAgorist 3月前

Fun day: up 18% first thing in AM, then down 17%, only to recover 5%. If you only looked at the modest 3.8% green at the end of the day, you might have no clue as to the action. Unless, of course, you've been here for more than a few days.

; - )

Must remember to keep powder dry and trigger finger limber for another one like that.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター